1-3 of 3
Tao Shi, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Extended Dosing of Oral Azacitidine (CC-486) for 14 and 21 Days Provides More Effective Methylation Reversal Than a 7-Day Schedule

Eric Laille, MS, Tao Shi, PhD, Guillermo Garcia-Manero, MD, Christopher R. Cogle, MD, Steven D. Gore, MD, Keshava J. Kumar, PhD, Barry S. Skikne, MD, Kyle J. MacBeth, PhD
Journal: Blood
Blood (2012) 120 (21): 1337.
https://doi.org/10.1182/blood.V120.21.1337.1337
Published: 2012
Journal Articles

Oral Azacitidine (AZA) Activity in Patients with Acute Myelogenous Leukemia (AML)

Steven D. Gore, MD, Christopher R. Cogle, MD, Barry Skikne, MD, Eric Laille, MS, Tao Shi, PhD, Kyle J. MacBeth, PhD, Heidi Giordano, MA, MBA, Guillermo Garcia-Manero
Journal: Blood
Blood (2011) 118 (21): 1546.
https://doi.org/10.1182/blood.V118.21.1546.1546
Published: 2011
Journal Articles

Identification of a DNA Methylation Predictive Signature of Overall Survival in Higher-Risk MDS Patients Treated with Azacitidine,

Tao Shi, PhD, Ludmila Danilova, PhD, Xiaolong Luo, PhD, Lela M. Lucy, MS, CL Beach, PharmD, Leslie Cope, PhD, James G. Herman, MD, Kyle J. MacBeth, PhD
Journal: Blood
Blood (2011) 118 (21): 3815.
https://doi.org/10.1182/blood.V118.21.3815.3815
Published: 2011